Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share - Summary Of Diluted Shares Outstanding (Detail)

v3.22.1
Net Loss Per Share - Summary Of Diluted Shares Outstanding (Detail) - shares
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Series C Convertible Preferred Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of EPS 0 2,566,186
Stock Option [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of EPS 0 432,500
Common stock issued under the Backstop Agreement [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of EPS 9,600,031 0
Restricted stock grants with only service conditions [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Antidilutive Securities Excluded from Computation of EPS 3,108,277 0